These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 9709945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.
    McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G.
    Metabolism; 2004 Apr; 53(4):495-9. PubMed ID: 15045698
    [Abstract] [Full Text] [Related]

  • 3. Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.
    Abbasi F, Farin HM, Lamendola C, McGraw L, McLaughlin T, Reaven GM.
    Metabolism; 2008 Aug; 57(8):1108-14. PubMed ID: 18640389
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM.
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers.
    Abbasi F, McLaughlin T, Lamendola C, Reaven GM.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1251-4. PubMed ID: 10720071
    [Abstract] [Full Text] [Related]

  • 9. Measurements of insulin-mediated glucose disposal are stable over time.
    Facchini F, Humphreys MH, Jeppesen J, Reaven GM.
    J Clin Endocrinol Metab; 1999 May; 84(5):1567-9. PubMed ID: 10323381
    [Abstract] [Full Text] [Related]

  • 10. Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers.
    Abbasi F, McLaughlin T, Lamendola C, Yeni-Komshian H, Tanaka A, Wang T, Nakajima K, Reaven GM.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3903-6. PubMed ID: 10566626
    [Abstract] [Full Text] [Related]

  • 11. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals.
    Farin HM, Abbasi F, Reaven GM.
    Am J Cardiol; 2006 Oct 15; 98(8):1053-6. PubMed ID: 17027570
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort.
    Luke JN, Brown AD, Brazionis L, O'Dea K, Best JD, McDermott RA, Wang Z, Wang Z, Rowley KG.
    Eur J Prev Cardiol; 2013 Apr 15; 20(2):246-53. PubMed ID: 22345691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between obesity, insulin resistance, and coronary heart disease risk.
    Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM.
    J Am Coll Cardiol; 2002 Sep 04; 40(5):937-43. PubMed ID: 12225719
    [Abstract] [Full Text] [Related]

  • 20. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
    Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Horio T, Yoshimasa Y, Harano Y.
    Am J Hypertens; 2004 Mar 04; 17(3):228-32. PubMed ID: 15001196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.